These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8343631)

  • 1. Explaining variations in prescribing costs across England.
    Morton-Jones T; Pringle M
    BMJ; 1993 Jun; 306(6894):1731-4. PubMed ID: 8343631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prescribing unit with index including both age and sex in assessing general practice prescribing costs.
    Purves IN; Edwards C
    BMJ; 1993 Feb; 306(6876):496-8. PubMed ID: 8448463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informing prescribing allocations at district level in England.
    Rice N; Carr-Hill R; Roberts D; Lloyd D
    J Health Serv Res Policy; 1997 Jul; 2(3):154-9. PubMed ID: 10180376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of a needs based capitation formula for allocating prescribing budgets to health authorities and primary care groups in England: regression analysis.
    Rice N; Dixon P; Lloyd DC; Roberts D
    BMJ; 2000 Jan; 320(7230):284-8. PubMed ID: 10650026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explaining variations in general practice prescribing costs per ASTRO-PU (age, sex, and temporary resident originated prescribing unit).
    Whynes DK; Baines DL; Tolley KH
    BMJ; 1996 Feb; 312(7029):488-9. PubMed ID: 8597684
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific therapeutic group age-sex related prescribing units (STAR-PUs): weightings for analysing general practices' prescribing in England.
    Lloyd DC; Harris CM; Roberts DJ
    BMJ; 1995 Oct; 311(7011):991-4. PubMed ID: 7580642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, sex, and temporary resident originated prescribing units (ASTRO-PUs): new weightings for analysing prescribing of general practices in England.
    Roberts SJ; Harris CM
    BMJ; 1993 Aug; 307(6902):485-8. PubMed ID: 8305014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of prescribing costs amongst single-handed general practitioners.
    Gill PS; Roalfe A
    J Clin Pharm Ther; 2001 Dec; 26(6):433-5. PubMed ID: 11722680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using unemployment rates to predict prescribing trends in England.
    Pringle M; Morton-Jones A
    Br J Gen Pract; 1994 Feb; 44(379):53-6. PubMed ID: 8179946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of practice characteristics on prescribing in fundholding and non-fundholding general practices: an observational study.
    Wilson RP; Hatcher J; Barton S; Walley T
    BMJ; 1996 Sep; 313(7057):595-9. PubMed ID: 8806250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundholders' prescribing costs: the first five years.
    Harris CM; Scrivener G
    BMJ; 1996 Dec; 313(7071):1531-4. PubMed ID: 8978232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing costs in dispensing practices.
    Morton-Jones TJ; Pringle MA
    BMJ; 1993 May; 306(6887):1244-6. PubMed ID: 8499855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in prescribing by general practitioner fundholders: an observational study.
    Wilson RP; Buchan I; Walley T
    BMJ; 1995 Nov; 311(7016):1347-50. PubMed ID: 7496289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of a general practice group intervention on prescribing costs and patterns.
    Walker J; Mathers N
    Br J Gen Pract; 2002 Mar; 52(476):181-6. PubMed ID: 12030659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme.
    Stewart-Brown S; Surender R; Bradlow J; Coulter A; Doll H
    BMJ; 1995 Dec; 311(7019):1543-7. PubMed ID: 8520399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs.
    Bradlow J; Coulter A
    BMJ; 1993 Nov; 307(6913):1186-9. PubMed ID: 8251847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17.
    Heald AH; Livingston M; Bien Z; Moreno GYC; Laing I; Stedman M
    Int J Clin Pract; 2018 Apr; 72(4):e13080. PubMed ID: 29537664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating relationships between a range of potential indicators of general practice prescribing: an observational study.
    Avery AJ; Heron T; Lloyd D; Harris CM; Roberts D
    J Clin Pharm Ther; 1998 Dec; 23(6):441-50. PubMed ID: 10048505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explaining outputs of primary health care: population and practice factors.
    Baker D; Klein R
    BMJ; 1991 Jul; 303(6796):225-9. PubMed ID: 1653065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of regression analysis to explain the variation in prescribing rates and costs between family practitioner committees.
    Forster DP; Frost CE
    Br J Gen Pract; 1991 Feb; 41(343):67-71. PubMed ID: 2031739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.